The study presents a procedure to acquire a colloidal silver-based antimicrobial polymer composition. Carboxymethylstarch (CMS) as polymer matrix, and colloidal silver particles (Ag 0 ) obtained by in situ synthesis with silver nitrate and sodium citrate as reducing agent, were used. In solution, the presence of COOH and OH groups in carboxymethylstarch directs to silver complexation and acquirement of a stable suspension of silver particles. Due to the presence of colloidal silver particles, the composition presents bacteriostatic activity and in association with some drugs (acetylsalicylic acid or diclofenac sodium) pharmaceutical compositions can be obtained, which are useful in the prevention and treatment of some infections or diseases. The compositions were characterized by FTIR spectroscopy, UV-vis spectrophotometry, particle size analysis and zeta potential measurements. Drug release tests were done in vitro in phosphate buffer solution (pH=7.4, at 37 0 C).
Introduction
In the past decades, metal nanoparticles have been extensively investigated for their properties and for providing important functional structures. Incorporating them into polymeric matrices was proved to be an effective method to enhance the functions of the polymeric materials [1] . These metal nanoparticle/polymer nanocomposite materials exhibited novel combination properties of both metal nanoparticles and polymers and were attractive for the potential applications in catalysis, optics, electronics, sensor and biomedicine [2] . It is well known that stimuli responsive hydrogels represent a perspective of functional materials and has attracted considerable attention for their potential applications in the biomedical and biotechnological field [3, 4] . Silver (Ag) is an important commercially available metal and its nanoparticles are superior to other nanosized metal particles for their excellent electrical conductivity [5] , antimicrobial effects [6] and optical properties [7] . Currently, several successful methods have been carried out to obtain functional metal nanoparticles/hydrogel nanocomposites. For example, Willner et.al. [8, 9] prepared gold nanoparticle/poly(N-isopropylacrylamide) (PNIPA) composite hydrogels with electrochemical properties by physically incorporating of nanoparticles into PNIPA matrix. A similar method was adopted in the preparation of Ag/polyvinyl alcohol (PVA) composites with optical properties [10] . However, the homogeneous dispersion of metal nanoparticles in these hydrogels is a key challenge due to the easy agglomeration of nanoparticles and the high viscosity of hydrogels [11] . A more effective approach reported in literature [12, 13] is the in situ reduction of metal ions in the hydrogels. In this method, the metal ions were anchored in the hydrogel network by the functional groups of the hydrogels before in situ reduction, so that they could effectively inhibit the aggregation of the metal particles.
Also, silver-based antibacterial composite materials attract attention because of their long-term biocidal activity, low volatility and nontoxicity of active silver ion to mammalian cells [14] . The polymer structures obtained by inclusion of ionic or metallic silver (Ag + , Ag 0 ) in the composition were studied due to their potential applications in medical or pharmaceutical field, to achieve biocompatible implants with antimicrobial properties (contact lens, catheters, sutures, scaffolds for tissue engineering), drug delivery systems [15] [16] [17] , filters for drinking water [18] . Contact lenses are often exposed to one or more microorganisms during wear, storage and handling. They can provide surfaces onto which the microorganisms can adhere and then proliferate to form a colony. The microbial adherence and colonization of contact lenses may enable microorganisms to proliferate and to be retained on the ocular surface for prolonged periods and thereby may cause infection or other deleterious effects on the ocular health of the eye in which the lens is used. One approach is to incorporate antimicrobial compounds into a polymeric composition for moulding a contact lens. For example, Chalkley et al. [19] , disclosed that some germicidal agents were incorporated into contact lenses, and that antimicrobial agents may be added to the monomer before polymerization and locked into the polymeric structure of the lens [20] , or contact lenses having antimicrobial properties may be made from quaternary ammonium group containing organosilicone polymers [21, 22] .
Other efforts were done about an aqueous suspension of silver-based materials. A uniform and stable emulsion is believed to be advantageous in many fields, for instance, directly coating of biomaterials, devices or medical textiles in the biologic or therapeutical applications, spraying or dispersing into the circumstance for hygienic purpose. Most of presented materials have to use additional surfactant, reductant, emulsifier or other agents which usually cause side-effects or can be toxic. Meanwhile, chitosan, is widely used (a natural polysaccharide deriving from chitin) because of its excellent properties, such as nontoxicity, biodegradability, biocompatibility and antibacterial character [23] [24] [25] . Another important property of chitosan is that the amino and hydroxyl groups can form chelate complex with silver ion [26] .
In this study, carboxymethylstarch obtained by starch modified with monochloroacetic acid, according to literature cited method [27, 28] , was used. Carboxymethylstarch due to physico-chemical properties (water solubility, biocompatibility, and presence of carboxyl and hydroxyl groups in its structure) can be utilized to obtain some stable compositions with colloidal silver particles. A stable silver colloidal suspension in aqueous solution of CMS was prepared from a mixture of silver nitrate and sodium citrate as reducing agent. The carboxymethylstarch suspension doped with silver particles was used for physical complexation with acetylsalicylic acid or diclofenac sodium to obtain antibacterial compositions with possible pharmaceutical applications. The in vitro delivery of acetylsalicylic acid or diclofenac sodium in phosphate buffer solution pH 7.4 at 37 0 C temperature was studied.
Results and discussion
In Figure 1 , FTIR spectra of the synthesized matrix (CMS-Ag), CMS-Ag/diclofenac sodium, and CMS-Ag/acetylsalicylic acid systems are presented. In all the three spectra the presence of some absorption bands characteristic to −COO -groups are noticed. Also, in the case of matrix/drug systems the presence of some absorption bands characteristic to the two drugs is observed.
Fig. 1.
FTIR spectra: 1-CMS-Ag matrix; 2-CMS-Ag/diclofenac sodium; 3-CMSAg/acetylsalicylic acid.
In Table 1 are presented the most representative FTIR absorption bands recorded in polymer matrix structure and in matrix/drug systems.
In Figure 2 the UV-vis spectrum of CMS-Ag matrix obtained by in situ synthesis of colloidal silver particles using silver nitrate and sodium citrate as reducing agent at 1/2 molar ratio, is presented. In UV-vis spectrum, the silver absorption at 400 nm wavelength approximately is noticed. In the case of CMS-Ag/drug systems subjected to dialysis in phosphate buffer solution (pH 7.4), no UV absorption was noticed at 400 nm wavelength due to extremely low concentration of silver. In these cases, the determination of UV absorbance was done at 275 nm for diclofenac sodium and at 295 nm for acetylsalicylic acid.
Analysis of dimensional distribution of polymer matrix particles (CMS-Ag) and of the matrix/drug systems (CMS-Ag/drugs) is presented in Figures 3, 4 and the measurement results in Table 2 . The measurements of particles size distribution were achieved using suspensions of the respective systems, before film forming. The dimensional analysis emphasizes that the polymer matrix as well as the matrix/drug systems have close values and approximately 90 wt.% of the total volume of particles existent in the system are smaller than 475 μm. The particles dimension and in general the specific surface have influence on the degree and delivery rate of drugs from system, due to the diffusion rate growth of dialysis medium. Also, it is noticed that the dimensional distribution of particles (span) varies between 1.67-1.73 in the case of the matrix and 1.62-1.69 in the case of matrix/drug systems, and dimensional uniformity is around 0.5, meaning that the polydispersity is reduced. The electrical conductivity and zeta potential were studied on 28-40 0 C temperature intervals. In all cases, a linear growth of the electrical conductivity with temperature is noticed, but zeta potential values are differently influenced by temperature (Figs. 5,  6 ). Zeta potential refers to electrostatic potential generated by ions accumulation at the surface of particle (or colloid) organized in a double electric layer built up of Stern layer and a diffusion layer. Zeta potential was measured at pH values: CMS (pH=5.20), CMS-Ag (pH=5.98), CMS-Ag/acetylsalicylic acid (pH=4.88), CMSAg/diclofenac sodium (pH=7.43). CMS-Ag/drug systems have zeta potential values comprising between -31.4 mV and -39.7 mV, the lowest values are recorded at human body temperature (37 0 C). In general, it is known that zeta potential of stable colloidal solutions has to be situated outside ± 30 mV domain. Matrix/drug systems achieved have higher absolute zeta potential values than those earlier mentioned, consequently the systems present stability and do not deposit in time. Diclofenac sodium and acetylsalicylic acid released were determined from UV spectra recorded after dialysis of matrix/drug systems and from calibration curves ( Fig. 7) and adequate linear equations respectively, Y=A+BX (Y -absorbance recorded at different dialysis periods, X -concentration of drug released, A, Bequation coefficients). UV absorbance was recorded at λ=275 nm for diclofenac sodium and 295 nm in case of acetylsalicylic acid. In similar conditions were done the dialysis of the polymer matrix without drug and the recorded absorbance was substracted from the absorbance's of the respective systems at the same periods. The morphology of the film surface was studied by light transmission optical microscopy ( Fig. 10) . The film obtained from CMS presents a smooth surface, which is homogeneous and uniform (Fig. 10 a) , while the film obtained from CMS-Ag presents a heterogeneous aspect in which we can notice the presence and dispersion of single or associated silver microparticles (Fig. 10 b) . In the case of the matrix/drug systems ( Fig. 10 c-d ) the surfaces are also heterogeneous due to the presence of the three species: polymer-drug-silver associated microparticles. We can notice the presence of microparticles of drug obtained after solvent evaporation, and those of single or associated silver microparticles surrounded by polymer that forms the continuous phase.
Conclusions
The composition obtained by chemical treatment of CMS aqueous solution with AgNO 3 and sodium citrate as reducing agent directs to the obtainment of an antimicrobial composition on account of the presence of colloidal silver particles. Acetylsalicylic acid and diclofenac sodium released from the matrix/drug systems in phosphate buffer solution pH=7.4, at 37 0 C temperature, were studied. The drug release percentage and drug release rate depend on the drug structure, dialysis time, particles size (specific surface), design and matrix structure. Acetylsalicylic acid reaches a release degree of 70 wt.% only after 24 hours of dialysis time, and diclofenac sodium after 320 hours.
Zeta potential measurements can be a useful tool for characterizing colloidal drug delivery systems, especially when used in conjunction with other techniques, such as particle size distribution. They can give information on the surface properties of the carriers, stability of colloidal solutions, the association and organization manner of drug molecules in a system and its release in different media.
Experimental part

Materials
Carboxymethylstarch synthesized in laboratory [28] , silver nitrate, sodium citrate (C 6 H 5 O 7 Na 3 ⋅5½ H 2 O) (Fluka reactives) without further purifications, were used. Acetylsalicylic acid and diclofenac sodium (Iassyfarm, Romania) were pharmaceutical products. Phosphate buffer solution (pH=7.4) was prepared from 0.5M Na 2 HPO 4 and 0.5M NaH 2 PO 4 aqueous solutions (volumetric ratio 4.5/1), followed by pH adjustment (if necessary) with 0.1 N acid or basic solution.
Synthesis
For CMS-Ag/diclofenac sodium and CMS-Ag/acetylsalicylic acid drug delivery systems achievement, carboxymethylstarch doped with silver colloidal particles (obtained by in situ synthesis with silver nitrate and sodium citrate as reducing agent), was used [28] . To obtain the polymer matrix with antibacterial character given by presence of colloidal silver particles, CMS polymer (4 g) was dissolved under agitation in 150 ml bidistilled water at 65-70 0 C. Then, 4 ml aqueous solution that contained 4,257·10 -4 moles sodium citrate (C 6 H 5 O 7 Na 3 ·5½ H 2 O) as reducing agent, was added. After 30 minutes, at the boiling temperature of the solution, 4 ml aqueous solution that contained 2,141·10 -4 moles AgNO 3 was gradually added and maintained under agitation for 2 h. The gravimetric ratio anion/cation (COO -/ Ag + ) used was approximately 2.43/1. Before AgNO 3 solution introduction, the reaction mixture was colourless, then it became white-spliced, and finally violet-brown indicating the formation and presence of silver particles suspended in the reaction mass. The suspension of carboxymethylstarch doped with colloidal silver particles (CMS-Ag) was used to carry out the matrix/drug systems. The concentration of CMS polymer in solution was 2.33 wt.%. Silver concentration (theoretically calculated) in CMS-Ag solution was 0.135⋅10 -2 mol/L. During the reduction reaction of silver nitrate with sodium citrate and acquirement of colloidal silver particles in the reaction mass, metallic silver (Ag o ) (formed in the reduction reaction), as well as ionic silver (Ag + ) resulted by silver nitrate dissociation, are present. The probability of silver ions present in the reaction mass might contribute, in the given reaction conditions, to the obtainment of some complexes with the carboxylic groups present in CMS, thus generating the stabilization of the obtained suspension. The possible chemical structures proposed for CMS and CMS-Ag are presented in scheme 1.
Scheme 1. Possible chemical structures for CMS and CMS-Ag.
To perform the CMS-Ag/acetylsalicylic acid system, 0.257 g acetylsalicylic acid were dissolved in 3 ml distilled water, then the solution was added to 6.5 g CMS 3.84 wt.% aqueous solution (0.2496 g CMS). After 30 minutes homogenization at 25 0 C temperature, 10.8 g CMS-Ag 2.33 wt.% aqueous solution (0.2516 g CMS) was added and stirring was continued for 2 h, then it was left overnight for physical complexation. The achievement of CMS-Ag/diclofenac sodium system was done using the same chemical reagent quantities and reaction conditions. After physical complexation of the drugs, a turbidity modification of the systems was observed, but the achieved systems presented good time stability. These stable dispersions were characterized by particle size distribution and zeta potential. Next, the mixtures were used for films casting in glass moulds (100×20×2 mm), and the obtained films were air dried 72 h for solvent evaporation. Drugs concentration in the two systems (films) was 33.90 wt.%. The obtained films were next utilized, for in vitro drug release studies, by dialysis in buffer solutions. In scheme 2 are presented the chemical structures of the two drugs.
[2-(2.6-dichloranyline) phenyl] acetic acid (diclofenac sodium) acetylsalicylic acid Scheme 2. Chemical structure of drugs.
